Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

Prognostic value of morphology and hormone receptor status in breast cancer - a population-based study.

Allemani C, Sant M, Berrino F, Aareleid T, Chaplain G, Coebergh JW, Colonna M, Contiero P, Danzon A, Federico M, Gafà L, Grosclaude P, Hédelin G, Macè-Lesech J, Garcia CM, Paci E, Raverdy N, Tretarre B, Williams EM.

Br J Cancer. 2004 Oct 4;91(7):1263-8.

2.

Tumor location of the lower-inner quadrant is associated with an impaired survival for women with early-stage breast cancer.

Sarp S, Fioretta G, Verkooijen HM, Vlastos G, Rapiti E, Schubert H, Sappino AP, Bouchardy C.

Ann Surg Oncol. 2007 Mar;14(3):1031-9. Epub 2006 Dec 20.

PMID:
17176985
3.

Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.

Fournier A, Fabre A, Mesrine S, Boutron-Ruault MC, Berrino F, Clavel-Chapelon F.

J Clin Oncol. 2008 Mar 10;26(8):1260-8. doi: 10.1200/JCO.2007.13.4338.

5.
6.

Relationship between established breast cancer risk factors and risk of seven different histologic types of invasive breast cancer.

Li CI, Daling JR, Malone KE, Bernstein L, Marchbanks PA, Liff JM, Strom BL, Simon MS, Press MF, McDonald JA, Ursin G, Burkman RT, Deapen D, Spirtas R.

Cancer Epidemiol Biomarkers Prev. 2006 May;15(5):946-54.

7.

Menopausal hormone therapy and risk of clinical breast cancer subtypes.

Slanger TE, Chang-Claude JC, Obi N, Kropp S, Berger J, Vettorazzi E, Braendle W, Bastert G, Hentschel S, Flesch-Janys D.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1188-96. doi: 10.1158/1055-9965.EPI-09-0002. Epub 2009 Mar 31.

8.

Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.

Grann VR, Troxel AB, Zojwalla NJ, Jacobson JS, Hershman D, Neugut AI.

Cancer. 2005 Jun 1;103(11):2241-51.

9.

Fine-needle aspiration cytologic features of four special types of breast cancers: mucinous, medullary, apocrine, and papillary.

Haji BE, Das DK, Al-Ayadhy B, Pathan SK, George SG, Mallik MK, Abdeen SM.

Diagn Cytopathol. 2007 Jul;35(7):408-16.

PMID:
17580344
10.

Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.

Martín M, Rodríguez-Lescure A, Ruiz A, Alba E, Calvo L, Ruiz-Borrego M, Munárriz B, Rodríguez CA, Crespo C, de Alava E, López García-Asenjo JA, Guitián MD, Almenar S, González-Palacios JF, Vera F, Palacios J, Ramos M, Gracia Marco JM, Lluch A, Alvarez I, Seguí MA, Mayordomo JI, Antón A, Baena JM, Plazaola A, Modolell A, Pelegrí A, Mel JR, Aranda E, Adrover E, Alvarez JV, García Puche JL, Sánchez-Rovira P, Gonzalez S, López-Vega JM; GEICAM 9906 Study Investigators.

J Natl Cancer Inst. 2008 Jun 4;100(11):805-14. doi: 10.1093/jnci/djn151. Epub 2008 May 27.

11.

Evaluation of steroid hormone receptors with respect to tumor cellularity.

Geppert M, Smyczek-Gargya B, Dietl J, Schneider H.

Zentralbl Pathol. 1993 Aug;139(3):217-9.

PMID:
8218122
12.

[Analysis of prognostic factors in breast cancer at University Hospital for Tumors].

Lesar M, Stanec M, Oresić T.

Acta Med Croatica. 2006;60(1):35-41. Croatian.

PMID:
16802570
13.

Menopausal hormone therapy and other breast cancer risk factors in relation to the risk of different histological subtypes of breast cancer: a case-control study.

Rosenberg LU, Magnusson C, Lindström E, Wedrén S, Hall P, Dickman PW.

Breast Cancer Res. 2006;8(1):R11. Epub 2006 Feb 17.

14.

Invasive lobular carcinoma: to grade or not to grade.

Bane AL, Tjan S, Parkes RK, Andrulis I, O'Malley FP.

Mod Pathol. 2005 May;18(5):621-8.

15.

Risk factors for hormone receptor-defined breast cancer in postmenopausal women.

Rosenberg LU, Einarsdóttir K, Friman EI, Wedrén S, Dickman PW, Hall P, Magnusson C.

Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2482-8.

16.

A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.

Di Saverio S, Gutierrez J, Avisar E.

Breast Cancer Res Treat. 2008 Oct;111(3):541-7. Epub 2007 Nov 18.

PMID:
18026874
17.

Breast carcinoma in women 35 years and younger: a pathological study.

Fernandopulle SM, Cher-Siangang P, Tan PH.

Pathology. 2006 Jun;38(3):219-22.

PMID:
16753742
18.

Endocrine organ metastases in subjects with lobular carcinoma of the breast.

Bumpers HL, Hassett JM Jr, Penetrante RB, Hoover EL, Holyoke ED.

Arch Surg. 1993 Dec;128(12):1344-7.

PMID:
8250706
19.

Signet-ring cell carcinoma of the breast.

Liu SM, Chen DR.

Pathol Int. 2000 Jan;50(1):67-70.

PMID:
10692181
20.

[Immunohistochemical investigation of steroid hormones (ER, PR) in breast cancer].

Mchedlishvili MIu, Gabunia UA, Makharoblidze ER, Burnadze KT, Piradashvili DZ.

Georgian Med News. 2005 Feb;(119):65-7. Russian.

PMID:
15834186

Supplemental Content

Support Center